These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15011700)

  • 1. Clinical trials: the pitfalls of interpretation.
    Lokhandwalla Y; Dalvi B
    Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpreting results from thrombolytic megatrials: distinguishing fact from fiction.
    Brophy JM
    Can J Cardiol; 1996 Jan; 12(1):89-92. PubMed ID: 8595575
    [No Abstract]   [Full Text] [Related]  

  • 3. Once more with GUSTO.
    Jaffe AS
    Contemp Intern Med; 1993 Jul; 5(7):9-13. PubMed ID: 10171969
    [No Abstract]   [Full Text] [Related]  

  • 4. [GISSI 2; the beginning of the end or the end of the beginning for tissue plasminogen activator in acute myocardial infarct?].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1990 Sep; 134(35):1711-2. PubMed ID: 2120596
    [No Abstract]   [Full Text] [Related]  

  • 5. Bridging the gap between statistical analysis and decision making in public health research.
    Stangl DK
    Stat Med; 2005 Feb; 24(4):503-11. PubMed ID: 15678414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biased articles.
    Friedman JH
    Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
    [No Abstract]   [Full Text] [Related]  

  • 7. Tissue plasminogen activator was cost-effective compared to streptokinase in only selected patients with acute myocardial infarction.
    Kent DM; Vijan S; Hayward RA; Griffith JL; Beshansky JR; Selker HP
    J Clin Epidemiol; 2004 Aug; 57(8):843-52. PubMed ID: 15485737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dishonesty in clinical trials is expensive for the society 3].
    Waldorff S
    Ugeskr Laeger; 2003 Jun; 165(26):2672-3; author reply 2673-4. PubMed ID: 12886557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dishonesty in clinical trials is expensive for the society 2].
    Lund BA; Nordby G
    Ugeskr Laeger; 2003 Jun; 165(26):2672. PubMed ID: 12886556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dishonesty in clinical trials is expensive for the society 1].
    Heslet L; Nielsen JD; Schierbeck J
    Ugeskr Laeger; 2003 Jun; 165(26):2671-2. PubMed ID: 12886555
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials.
    Lachin JM
    Stat Med; 2004 May; 23(10):1519-21. PubMed ID: 15122730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 13. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
    Hammerschmidt D
    Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
    [No Abstract]   [Full Text] [Related]  

  • 14. [No bluff to be discovered in clinical trials].
    Berglund T
    Lakartidningen; 2009 Mar 25-31; 106(13):952-3. PubMed ID: 19441200
    [No Abstract]   [Full Text] [Related]  

  • 15. [ACCOMPLISH and the risks with company sponsored clinical trials].
    Furberg C
    Lakartidningen; 2009 Feb 11-17; 106(7):450. PubMed ID: 19350775
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials in India: balancing economic opportunity with the public health context.
    Dandona L
    Natl Med J India; 2006; 19(2):57-9. PubMed ID: 16756189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical researchers and pharmaceutical industry. Dangerous liaisons].
    Roos JC
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1668-71. PubMed ID: 10494304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest in dermatology.
    Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R
    Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small study on industry trial sponsorship leads to big questions about quality and bias.
    Twombly R
    J Natl Cancer Inst; 2007 Jul; 99(13):988-90. PubMed ID: 17596566
    [No Abstract]   [Full Text] [Related]  

  • 20. Validity of the GUSTO trial's main conclusion--author's reply. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Stringer KA
    Pharmacotherapy; 1997; 17(5):1043. PubMed ID: 9324198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.